Subscribe to industry newsletters

Search jobs

Dis-Chem profit rises on new acquisitions, medicine demand

Dis-Chem Pharmacies reported a rise in annual profit on Monday, 23 May, buoyed by acquisitions of new drugstores and stronger demand for medicines as Covid-19 lockdowns ease.
Source: Dis-Chem
Source: Dis-Chem

The pharmacy retail chain said the acquisitions of dozens of locations during the year ended 28 February, and its recent launch of a health insurance offering have helped the group broaden its focus.

"In the two months since launching medical insurance, uptake has exceeded our initial expectations," Dis-Chem said in a statement, although it warned the consumer environment remained "constrained."


Dis-Chem, which runs the second-largest chain of pharmacies in South Africa in competition with Clicks Group, said it administered 1.4 million Covid-19 vaccine doses during the year, resulting in R513m in revenue.

Total revenue climbed 15.7% to R30.4bn. Headline earnings per share, a key metric of profit for South African companies, jumped 27.6% to 99.2 cents for the year.



SOURCE

Reuters

Reuters, the news and media division of Thomson Reuters, is the world's largest multimedia news provider, reaching billions of people worldwide every day.


Go to: https://www.reuters.com/

About Muhammed Husain

Reporting by Muhammed Husain in Bengaluru; Editing by Subhranshu Sahu



Let's do Biz